Clorox (CLX)
NYSEConsumer StaplesHousehold & Personal ProductsSnapshot 2026-09-04
$93.06-1.30%
Close 2026-09-04 · 1-day change
NYSEConsumer StaplesHousehold & Personal ProductsSnapshot 2026-09-04
QuarterlyIQ Insights · CLX
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | 25.6% |
| Our one-year growth estimate | diamond | 8.3% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the opposite direction.
Price observations: 365 days
Most sensitive to long-term interest rates.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 17.3 percentage points more one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-09-04 · Compared with 18 industry peers · Company calendar date is not available
CLX — CEO transition
Dated 2026-05-28
CEO — Linda Rendle: Ms. Rendle is stepping down as CEO for health reasons but will remain in an advisory role.
Why it matters: The new CEO may change Clorox's focus and plans. Watching this will help understand future performance.
Watch forNew leaders have a clear and positive plan after the transition.
Also watch forLeaders do not have a clear strategy. This creates uncertainty.
Why it matters: A return to organic sales growth is key for Clorox's recovery. It signals improved demand and execution.
Supportive ifOrganic sales growth of 3.5% to 4.5% in fiscal year 2027.
Worry ifOrganic sales decline continues or growth is below 3.5%.
Why it matters: Gross margin trends will indicate how well Clorox is managing costs and pricing pressures.
Worry ifGross margin stays steady or gets better compared to last quarter.
Less concerning ifGross margin drops more, making the financial outlook worse.
Why it matters: The new CEO will shape Clorox's future direction and growth strategy. Leadership changes can impact investor confidence.
Watch forA press release announcing the appointment of a new CEO.
Also watch forNo announcement of a new CEO by the end of Q3 2026.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$111 on $10,000 · ±1.1% | How much price usually moves either way. |
| Bad day | $314 loss on $10,000 · 3.1% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $3,227 loss on $10,000 · 32.3% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: The new CEO's vision can shape Clorox's future strategy and performance.
Watch forAnnouncement of a new CEO with a strong track record in consumer goods.
Also watch forProlonged search without a clear candidate or direction.
Why it matters: A new CEO could change the company's direction and priorities.
Watch forAnnouncement of a new CEO who aligns with Clorox's growth strategy.
Also watch forNo CEO is chosen by the end of the search, showing possible instability.
Why it matters: Integrating GOJO is important for growth. It will help Clorox's health and hygiene products.
Supportive ifManagement shares news about successful steps from the GOJO acquisition. They see growth.
Worry ifThere are integration problems. These may delay expected growth and benefits.
Why it matters: Sales results will show if Clorox can reverse its sales decline. This is crucial for future growth.
Worry ifQ4 sales results show a decline worse than 6% year over year.
Less concerning ifQ4 sales results show a decline less than 6% year over year.
Why it matters: If Clorox integrates GOJO well, it can create new growth. This will improve its health and hygiene products.
Supportive ifSales from the GOJO segment are rising. This shows the integration is working.
Worry ifSales from the GOJO segment are flat or falling. This suggests there are integration problems.
Why it matters: A big drop in gross margin could mean cost problems and lower profits.
Worry ifGross margin decreases more than 300 basis points from the previous year.
Less concerning ifA gross margin drop of less than 250 basis points shows better cost control.
Why it matters: Better gross margin is important for Clorox's profits. It shows good cost control and pricing.
Supportive ifGross margin improvement towards 42% in fiscal year 2027.
Worry ifGross margin declines further below 41%.
Why it matters: A bigger drop in organic sales shows ongoing market share problems.
Worry ifOrganic sales dropped more than 9% from last year.
Less concerning ifOrganic sales drop is now less than 5%. This shows market share is recovering.
Why it matters: Gross margin trends will indicate how well Clorox is managing costs amidst challenges.
Worry ifGross margin remains above 43% despite cost pressures and shows signs of recovery.
Less concerning ifGross margin is under 40%. This shows there are cost management problems.
Why it matters: EPS growth guidance shows management thinks profits will improve. They believe in recovery.
Supportive ifGuidance for diluted EPS between $5.41 and $5.71, indicating growth.
Worry ifGuidance for diluted EPS falls below $5.41.
Why it matters: The company expects organic sales to grow 3.5% to 4.5% in FY27. This signals recovery from prior declines.
Supportive ifOrganic sales growth guidance of 3.5% to 4.5% for FY27 is confirmed.
Worry ifOrganic sales growth guidance falls below 3.5% for FY27.
Why it matters: Management expects gross margin to be about 42% in FY27. This reflects ongoing cost pressures.
Worry ifGross margin stays at or above 42% in FY27. This shows good cost management.
Less concerning ifGross margin drops below 42% in FY27. This shows rising cost pressures.
Why it matters: Adjusted EPS guidance is expected to grow 3% to 8% in FY27. This reflects recovery from prior declines.
Supportive ifAdjusted EPS guidance for FY27 is confirmed between $5.70 and $6.00.
Worry ifAdjusted EPS guidance falls below $5.70 for FY27.